
    
      Clinical trial multicenter, phase III,open-label, prospective character to evaluate the
      efficacy and safety of Susanna Implant in patients with refractory glaucoma of both genders,
      of any race, aged above 18 years and diagnosed with glaucoma refractory.
    
  